Clinical Trial Update: Hepatic Arterial Infusion of Oxaliplatin and Fluorouracil Treatment of Advanced Primary Liver Cancer After TACE [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial evaluates hepatic arterial infusion of oxaliplatin and 5-fluorouracil for advanced hepatocellular carcinoma following prior transart…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Adrucil (5-fluorouracil)
• Eloxatin (oxaliplatin)

Snippet

Sponsor: Zhu Xu | Conditions: Advanced Adult Primary Liver Cancer | Phase 4 | Status: UNKNOWN